NEC and Aetion are exploring a collaboration to commercialize global access to real-world data from Japanese electronic health records for drug development TOKYO and NEW YORK , Feb. 18, 2025 /PRNewswire/ -- NEC Orchestrating Future Fund (NOFF), an ecosystem-based corporate venture capital (CVC) fund established in 2021 by NEC Corporation , today announced that it has invested in Aetion , the global leader in real-world evidence (RWE) technology and analytics. Additionally, NEC and Aetion are collaborating to use real-world data (RWD) from Japanese electronic health records (EHR) on Aetion's Substantiate ® application, powered by the Aetion Evidence Platform ® (AEP), to further drug development in life sciences companies in Japan , and ultimately worldwide.
"As Aetion redefines how healthcare organizations make critical decisions with enterprise-grade technology, this investment from NOFF demonstrates their vision of how our software can help decision makers in Japan and beyond," said Jeremy Rassen , ScD, chief executive officer and co-founder of Aetion. "We look forward to continued collaboration with NEC, innovating together to meet the global demand for decision-grade solutions that drive measurable change across the healthcare landscape." AEP is a scientifically validated software platform that enables the transformation of RWD to RWE using deep scientific methods from causal inference and critical insights from artificial intelligence (AI).
It provides rapid and transpa.
